Natixis Advisors
HZNP

Natixis Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,267
Closed -$2.76M 1536
2023
Q1
$2.76M Sell
25,267
-111,900
-82% -$12.2M 0.01% 857
2022
Q4
$15.6M Sell
137,167
-23,148
-14% -$2.63M 0.06% 355
2022
Q3
$9.92M Sell
160,315
-66,445
-29% -$4.11M 0.04% 436
2022
Q2
$18.1M Sell
226,760
-2,268
-1% -$181K 0.08% 291
2022
Q1
$24.1M Buy
229,028
+52,675
+30% +$5.54M 0.09% 243
2021
Q4
$19M Buy
176,353
+6,788
+4% +$731K 0.07% 294
2021
Q3
$18.6M Buy
169,565
+33,063
+24% +$3.62M 0.08% 268
2021
Q2
$12.8M Buy
136,502
+58,577
+75% +$5.49M 0.06% 344
2021
Q1
$7.17M Buy
77,925
+11,299
+17% +$1.04M 0.04% 478
2020
Q4
$4.87M Buy
66,626
+1,853
+3% +$136K 0.03% 566
2020
Q3
$5.03M Sell
64,773
-488
-0.7% -$37.9K 0.03% 521
2020
Q2
$3.63M Buy
+65,261
New +$3.63M 0.02% 612